BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

394 related articles for article (PubMed ID: 34566892)

  • 1. Molecular Genetics, Clinical Characteristics, and Treatment Outcomes of K
    Ngoc CTB; Dien TM; De Franco E; Ellard S; Houghton JAL; Lan NN; Thao BP; Khanh NN; Flanagan SE; Craig ME; Dung VC
    Front Endocrinol (Lausanne); 2021; 12():727083. PubMed ID: 34566892
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effectiveness and safety of long-term treatment with sulfonylureas in patients with neonatal diabetes due to KCNJ11 mutations: an international cohort study.
    Bowman P; Sulen Å; Barbetti F; Beltrand J; Svalastoga P; Codner E; Tessmann EH; Juliusson PB; Skrivarhaug T; Pearson ER; Flanagan SE; Babiker T; Thomas NJ; Shepherd MH; Ellard S; Klimes I; Szopa M; Polak M; Iafusco D; Hattersley AT; Njølstad PR;
    Lancet Diabetes Endocrinol; 2018 Aug; 6(8):637-646. PubMed ID: 29880308
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Sulfonylurea in the treatment of neonatal diabetes mellitus children with heterogeneous genetic backgrounds.
    Zhang M; Chen X; Shen S; Li T; Chen L; Hu M; Cao L; Cheng R; Zhao Z; Luo F
    J Pediatr Endocrinol Metab; 2015 Jul; 28(7-8):877-84. PubMed ID: 25781672
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Case report: Better late than never, but sooner is better: switch from CSII to sulfonylureas in two patients with neonatal diabetes due to KCNJ11 variants.
    Mancioppi V; Pozzi E; Zanetta S; Missineo A; Savastio S; Barbetti F; Mellone S; Giordano M; Rabbone I
    Front Endocrinol (Lausanne); 2023; 14():1143736. PubMed ID: 37251668
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Molecular and clinical features of K
    Hashimoto Y; Dateki S; Hirose M; Satomura K; Sawada H; Mizuno H; Sugihara S; Maruyama K; Urakami T; Sugawara H; Shirai K; Yorifuji T
    Pediatr Diabetes; 2017 Nov; 18(7):532-539. PubMed ID: 27681997
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical Characteristics, Molecular Features, and Long-Term Follow-Up of 15 Patients with Neonatal Diabetes: A Single-Centre Experience.
    Abali ZY; De Franco E; Karakilic Ozturan E; Poyrazoglu S; Bundak R; Bas F; Flanagan SE; Darendeliler F
    Horm Res Paediatr; 2020; 93(7-8):423-432. PubMed ID: 33498041
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prevalence of permanent neonatal diabetes in Slovakia and successful replacement of insulin with sulfonylurea therapy in KCNJ11 and ABCC8 mutation carriers.
    Stanik J; Gasperikova D; Paskova M; Barak L; Javorkova J; Jancova E; Ciljakova M; Hlava P; Michalek J; Flanagan SE; Pearson E; Hattersley AT; Ellard S; Klimes I
    J Clin Endocrinol Metab; 2007 Apr; 92(4):1276-82. PubMed ID: 17213273
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Early transition from insulin to sulfonylureas in neonatal diabetes and follow-up: Experience from China.
    Li X; Xu A; Sheng H; Ting TH; Mao X; Huang X; Jiang M; Cheng J; Liu L
    Pediatr Diabetes; 2018 Mar; 19(2):251-258. PubMed ID: 28791793
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Functional characterization of activating mutations in the sulfonylurea receptor 1 (ABCC8) causing neonatal diabetes mellitus in Asian Indian children.
    Balamurugan K; Kavitha B; Yang Z; Mohan V; Radha V; Shyng SL
    Pediatr Diabetes; 2019 Jun; 20(4):397-407. PubMed ID: 30861254
    [TBL] [Abstract][Full Text] [Related]  

  • 10. New insights into K
    Pipatpolkai T; Usher S; Stansfeld PJ; Ashcroft FM
    Nat Rev Endocrinol; 2020 Jul; 16(7):378-393. PubMed ID: 32376986
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Genetic Etiology of Neonatal Diabetes Mellitus in Vietnamese Infants and Characteristics of Those With
    Ngoc CTB; Dung VC; De Franco E; Lan NN; Thao BP; Khanh NN; Flanagan SE; Craig ME; Hoang NH; Dien TM
    Front Endocrinol (Lausanne); 2022; 13():866573. PubMed ID: 35518939
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Neonatal diabetes due to potassium channel mutation: Response to sulfonylurea according to the genotype.
    Garcin L; Mericq V; Fauret-Amsellem AL; Cave H; Polak M; Beltrand J
    Pediatr Diabetes; 2020 Sep; 21(6):932-941. PubMed ID: 32418263
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Successful transfer to sulfonylureas in KCNJ11 neonatal diabetes is determined by the mutation and duration of diabetes.
    Babiker T; Vedovato N; Patel K; Thomas N; Finn R; Männikkö R; Chakera AJ; Flanagan SE; Shepherd MH; Ellard S; Ashcroft FM; Hattersley AT
    Diabetologia; 2016 Jun; 59(6):1162-6. PubMed ID: 27033559
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Genotype-phenotype correlation of K
    Gopi S; Kavitha B; Kanthimathi S; Kannan A; Kumar R; Joshi R; Kanodia S; Arya AD; Pendsey S; Pendsey S; Raghupathy P; Mohan V; Radha V
    Pediatr Diabetes; 2021 Feb; 22(1):82-92. PubMed ID: 32893419
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Personalized medicine switching from insulin to sulfonylurea in permanent neonatal diabetes mellitus dictated by a novel activating ABCC8 mutation.
    Mak CM; Lee CY; Lam CW; Siu WK; Hung VC; Chan AY
    Diagn Mol Pathol; 2012 Mar; 21(1):56-9. PubMed ID: 22306677
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Personalized precision medicine in extreme preterm infants with transient neonatal diabetes mellitus.
    Kylat RI; Senguttuvan R; Bader MY
    J Pediatr Endocrinol Metab; 2017 May; 30(5):593-596. PubMed ID: 28350539
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical and genetic features of Argentinian children with diabetes-onset before 12months of age: Successful transfer from insulin to oral sulfonylurea.
    Taberner P; Flanagan SE; Mackay DJ; Ellard S; Taverna MJ; Ferraro M
    Diabetes Res Clin Pract; 2016 Jul; 117():104-10. PubMed ID: 27329029
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Neonatal diabetes: an expanding list of genes allows for improved diagnosis and treatment.
    Greeley SA; Naylor RN; Philipson LH; Bell GI
    Curr Diab Rep; 2011 Dec; 11(6):519-32. PubMed ID: 21993633
    [TBL] [Abstract][Full Text] [Related]  

  • 19. KATP channel mutations in infants with permanent diabetes diagnosed after 6 months of life.
    Rubio-Cabezas O; Flanagan SE; Damhuis A; Hattersley AT; Ellard S
    Pediatr Diabetes; 2012 Jun; 13(4):322-5. PubMed ID: 21981029
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Permanent neonatal diabetes due to activating mutations in ABCC8 and KCNJ11.
    Edghill EL; Flanagan SE; Ellard S
    Rev Endocr Metab Disord; 2010 Sep; 11(3):193-8. PubMed ID: 20922570
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.